EIR Par Pharmaceuticals Dec 2013

Carla Lundi FDA, Kim Thomas Cruse FDA$595.00 - Available Now

FDA investigators audited the Par Pharmaceuticals - Irvine, CA, United States facility and issued inspectional observation (via FDA 483) on 20 Dec 2013.

Product details

  • Category:
  • Inspection end: 20 Dec 2013
  • Location: Irvine, United States
  • FEI: 3004492248
Add To Cart